---
schema_version: "secwatch.filing_event.v1"
accession: "0001607062-22-000714"
form_type: "8-K"
ticker: "RGBP"
cik: "0001589150"
company_name: "Regen BioPharma Inc"
filed_at: "2022-11-18T23:59:59+00:00"
generated_at: "2026-06-21T15:51:39.370996+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Regen Biopharma issues 101.9M Series A Preferred and 16.9M common shares in debt-for-equity swap

## Summary
- Issued 101,880,008 shares of Series A Preferred to satisfy $511,500 convertible debt and $253,816 accrued interest.
- Issued 16,912,946 common shares to satisfy $25,369 accrued interest on a convertible note.
- Total debt and interest converted: $790,685 ($511,500 principal + $279,185 interest).
- Securities issued under Section 4(a)(2) private placement exemption; no underwriters or commissions.

## SEC filing metadata
- accession: 0001607062-22-000714
- form_type: 8-K
- ticker: RGBP
- cik: 0001589150
- company_name: Regen BioPharma Inc
- filed_at: 2022-11-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1589150/000160706222000714/0001607062-22-000714-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1589150/000160706222000714/rgbp111822form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001607062-22-000714
- JSON: https://secwatch.observer/filing/0001607062-22-000714.json
- Plain text: https://secwatch.observer/filing/0001607062-22-000714.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.